GABPB1 and hepatocellular carcinoma: Qi and colleagues discovered lncRNA GABPB1-AS1, which further decreases HCC cells’ antioxidant potential by inhibiting the production of PRDX5 (peroxiredoxin 5) peroxidase., thereby promoting erastin-induced ferroptosis, along with the finding that GABPB1 is both highly expressed and linked to a poor prognosis in HCC (247).